{"id":"W1448065076","doi":"10.1182/blood.v122.21.498.498","title":"Phase 1b Study Of The MDM2 Antagonist RG7112 In Combination With 2 Doses/Schedules Of Cytarabine","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacodynamics; Cytarabine; Internal medicine; Rash; Phases of clinical research; Pharmacokinetics; Refractory (planetary science); Pharmacology; Gastroenterology; Clinical trial; Oncology; Leukemia; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001023288,0.00009864811,0.0002459464,0.00008376761,0.00002242768,0.000004899373,0.00009440008,0.00004786236,0.0000345545],"category_scores_gemma":[0.00004387857,0.00006476501,0.00003791604,0.0003253362,0.00007695185,0.00004260831,0.00003324914,0.0001469297,0.000004178177],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002380485,"about_ca_system_score_gemma":0.00008819828,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005236201,"about_ca_topic_score_gemma":0.0002227643,"domain_scores_codex":[0.9991352,0.00005325427,0.0002674315,0.0001486434,0.0002796343,0.0001158297],"domain_scores_gemma":[0.9992875,0.00002113908,0.0001520395,0.0003732372,0.0001286929,0.00003741541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007119994,0.1213469,0.1673621,0.0003206046,0.0005851624,0.00007747323,0.003580314,0.00004924673,0.7018059,0.0006830186,0.0001517889,0.003325546],"study_design_scores_gemma":[0.1419698,0.0113031,0.2203726,0.0004530418,0.0006956694,0.00005664678,0.002284404,0.0002602783,0.6221894,0.0001310155,0.00008988359,0.0001941125],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977992,0.0001680898,0.00002478785,0.0001950748,0.00005380064,0.001187921,0.000006079114,0.00001359215,0.0005514264],"genre_scores_gemma":[0.9996665,0.00000976571,0.0001586339,0.0000296171,0.0000141901,0.00004806213,0.000008896376,0.00001670241,0.00004762025],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1412578,"threshold_uncertainty_score":0.264104,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009994532846563625,"score_gpt":0.2519459987357455,"score_spread":0.2419514658891818,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}